CRP and COVID-19: Earlier case series have reported RV dilation to be present in as much as 41% of patients with COVID-19 induced ARDS and 27% of patients had impaired RV function [9] and identified C-reactive protein (CRP) and D-dimer as associated biomarkers of RV dysfunction [9–11].